These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28389994)

  • 1. Neuroendocrine Tumors of the Breast.
    Visscher DW; Yasir S
    Endocr Pathol; 2017 Jun; 28(2):121-127. PubMed ID: 28389994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women.
    Sapino A; Righi L; Cassoni P; Papotti M; Gugliotta P; Bussolati G
    Mod Pathol; 2001 Aug; 14(8):768-76. PubMed ID: 11504836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic Characteristics of Solid Papillary Carcinoma of the Breast.
    Tan BY; Thike AA; Ellis IO; Tan PH
    Am J Surg Pathol; 2016 Oct; 40(10):1334-42. PubMed ID: 27438988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.
    Swarts DR; Ramaekers FC; Speel EJ
    Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 34betaE12 cytokeratin immunodetection in the differential diagnosis of neuroendocrine carcinomas of the breast.
    Papotti M; Sapino A; Righi L; Chiappone S; Bussolati G
    Appl Immunohistochem Mol Morphol; 2001 Sep; 9(3):229-33. PubMed ID: 11556750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of neuroendocrine carcinoma of the breast.
    Sapino A; Papotti M; Righi L; Cassoni P; Chiusa L; Bussolati G
    Ann Oncol; 2001; 12 Suppl 2():S115-7. PubMed ID: 11762336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Head to head: do neuroendocrine tumours in the breast truly exist?
    Rakha E; Tan PH
    Histopathology; 2022 Jul; 81(1):2-14. PubMed ID: 35133666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Histopathology of neuroendocrine tumors].
    Saint-André JP; Dupré F; Chenue F; Guyétant S
    Ann Endocrinol (Paris); 1997; 58(2):101-11. PubMed ID: 9239228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine differentiation correlates with hormone receptor expression and decreased survival in patients with invasive breast carcinoma.
    Kwon SY; Bae YK; Gu MJ; Choi JE; Kang SH; Lee SJ; Kim A; Jung HR; Kang SH; Oh HK; Park JY
    Histopathology; 2014 Apr; 64(5):647-59. PubMed ID: 24117859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Papillary and neuroendocrine breast lesions: the WHO stance.
    Tan PH; Schnitt SJ; van de Vijver MJ; Ellis IO; Lakhani SR
    Histopathology; 2015 May; 66(6):761-70. PubMed ID: 24845113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid papillary carcinoma of the breast: a pathologically and clinically distinct breast tumor.
    Saremian J; Rosa M
    Arch Pathol Lab Med; 2012 Oct; 136(10):1308-11. PubMed ID: 23020734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syntaxin-1 and Insulinoma-Associated Protein 1 Expression in Breast Neoplasms with Neuroendocrine Features.
    Turkevi-Nagy S; Báthori Á; Böcz J; Krenács L; Cserni G; Kővári B
    Pathol Oncol Res; 2021; 27():1610039. PubMed ID: 34764822
    [No Abstract]   [Full Text] [Related]  

  • 13. Carcinomas of the breast with endocrine differentiation: a review.
    Maluf HM; Koerner FC
    Virchows Arch; 1994; 425(5):449-57. PubMed ID: 7850068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. INSM1 Expression in Breast Neoplasms with Neuroedocrine Features.
    Metovic J; Castellano I; Marinelli E; Osella-Abate S; Sapino A; Cassoni P; Papotti M
    Endocr Pathol; 2021 Dec; 32(4):452-460. PubMed ID: 34008122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid neuroendocrine breast carcinomas: incidence, clinico-pathological features and immunohistochemical profiling.
    López-Bonet E; Alonso-Ruano M; Barraza G; Vazquez-Martin A; Bernadó L; Menendez JA
    Oncol Rep; 2008 Dec; 20(6):1369-74. PubMed ID: 19020716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer with neuroendocrine differentiation: an update based on the latest WHO classification.
    Tsang JY; Tse GM
    Mod Pathol; 2021 Jun; 34(6):1062-1073. PubMed ID: 33531618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytological study of 44 cases with solid papillary carcinoma and a systemic review of solid papillary carcinoma and neuroendocrine tumor of the breast.
    Yamada M; Otsuki Y; Ikeya T; Shimizu SI; Tanioka F; Ogawa H; Kobayashi H
    Diagn Cytopathol; 2023 Jun; 51(6):341-348. PubMed ID: 36748676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine carcinomas of the breast.
    Rovera F; Masciocchi P; Coglitore A; La Rosa S; Dionigi G; Marelli M; Boni L; Dionigi R
    Int J Surg; 2008; 6 Suppl 1():S113-5. PubMed ID: 19167937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid papillary carcinoma of the breast: A special entity needs to be distinguished from conventional invasive carcinoma avoiding over-treatment.
    Guo S; Wang Y; Rohr J; Fan C; Li Q; Li X; Wang Z
    Breast; 2016 Apr; 26():67-72. PubMed ID: 27017244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic cytological features of neuroendocrine differentiated carcinoma of the breast.
    Sapino A; Papotti M; Pietribiasi F; Bussolati G
    Virchows Arch; 1998 Sep; 433(3):217-22. PubMed ID: 9769124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.